These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38041175)

  • 1. Growth characteristics of early-stage (IA) lung adenocarcinoma and its value in predicting lymph node metastasis.
    Liu M; Mu J; Song F; Liu X; Jing W; Lv F
    Cancer Imaging; 2023 Dec; 23(1):115. PubMed ID: 38041175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct impacts of radiological appearance on lymph node metastasis and prognosis based on solid size in clinical T1 non-small cell lung cancer.
    Li Z; Pan C; Xu W; Zhao C; Pan X; Wang Z; Wu W; Chen L
    Respir Res; 2024 Feb; 25(1):96. PubMed ID: 38383329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple nomogram for predicting occult lymph node metastasis of non-small cell lung cancer from preoperative computed tomography findings, including the volume-doubling time.
    Karita R; Suzuki H; Onozato Y; Kaiho T; Inage T; Ito T; Tanaka K; Sakairi Y; Yoshino I
    Surg Today; 2024 Jan; 54(1):31-40. PubMed ID: 37129682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of lymph node metastasis of clinical stage IA non-small cell lung cancer based on the tumor volume doubling time.
    Nakahashi K; Shiono S; Nakatsuka M; Endo M
    Surg Today; 2022 Jul; 52(7):1063-1071. PubMed ID: 35044521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification.
    Hong JH; Park S; Kim H; Goo JM; Park IK; Kang CH; Kim YT; Yoon SH
    Korean J Radiol; 2021 Mar; 22(3):464-475. PubMed ID: 33169551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
    Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
    Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features and lymph node metastatic characteristics in patients with adenocarcinoma manifesting as part-solid nodule exceeding 3 cm in diameter.
    Li W; Zhou F; Wan Z; Li M; Zhang Y; Bao X; Zhang L; Shi J
    Lung Cancer; 2019 Oct; 136():37-44. PubMed ID: 31437662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
    Cho S; Song IH; Yang HC; Kim K; Jheon S
    Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer.
    Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
    Oncology; 2023; 101(8):473-480. PubMed ID: 37433283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.
    Setojima Y; Shimada Y; Tanaka T; Shigefuku S; Makino Y; Maehara S; Hagiwara M; Masuno R; Yamada T; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2020 Apr; 57(4):763-770. PubMed ID: 31746987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
    Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
    Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
    Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
    Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
    Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study.
    Zhao F; Zhao Y; Zhang Y; Sun H; Ye Z; Zhou G
    Acad Radiol; 2023 Dec; 30(12):2870-2879. PubMed ID: 37003873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X; Guo Y; Qian X
    Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers.
    Yin J; Xi J; Liang J; Zhan C; Jiang W; Lin Z; Xu S; Wang Q
    Clin Lung Cancer; 2021 Jul; 22(4):324-331. PubMed ID: 33789831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.